New Life for Research…or for Biotech Donors?

Published on

The day after President Bush
vetoed a bill to extend federally funded stem cell research, Arnold
breathed new life into California’s cash-strapped stem cell institute
by ordering the state to lend it $150 million from the general fund.

He got kudos nationally and around the state for moving stem cell
research forward in California and distancing himself from George W’s
brand of Republicanism. Overlooked was the fact that a major
beneficiary of the move, the biotech and pharmaceutical industry, has
donated $1.09 million to his committees.

The governor’s order came as he attended two fundraisers with W’s
father, giving biotech and other interests more chances for special
access. Sure, it’s a good thing the stem cell institute executives
won’t have to go hat in hand begging for donations to keep operating,
but Arnold’s largess with the taxpayer’s money came with no controls.

Without rules governing such things as ownership of discoveries and
payback to the state firmly in place, the beneficiaries of the loan
will be biotech and pharma, not the people of California who were
promised the benefits of ground-breaking stem cell research.

Consumer Watchdog
Consumer Watchdog
Providing an effective voice for American consumers in an era when special interests dominate public discourse, government and politics. Non-partisan.

Latest Videos

Latest Releases

In The News

Latest Report

Support Consumer Watchdog

Subscribe to our newsletter

To be updated with all the latest news, press releases and special reports.

More Releases